Tissue-based Quantification of 8-Hydroxy-2′-Deoxyguanosine in Human Prostate Biopsies Using Quantitative Fluorescence Imaging Analysis

Urology

Volumn 74, Issue 5, 2009, Pages 1174-1179

  Richardson, Tim ^a   McCanse, Webb ^a   Casale, George P ^a   Huang, Dali ^a   Tian, Jennifer ^a   Elkahwaji, Johny E ^a   Lele, Subodh ^a   Hemstreet, George P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MONOCLONAL ANTIBODY; PARAFFIN; PROTEINASE; RIBONUCLEASE;

ARTICLE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE BIOPSY; QUANTITATIVE ANALYSIS; STROMA; STUDENT T TEST;

AGED; BIOPSY; DEOXYGUANOSINE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PILOT PROJECTS; PROSTATE;

EID: 70350565066     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.052     Document Type: Article

References (26)

1. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
2. Johnson T.M., Yu Z.X., Ferrans V.J., et al. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA 93 (1996) 11848-11852
3. Nakae D., Kobayashi Y., Akai H., et al. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 57 (1997) 1281-1287
4. Malins D.C., Polissar N.L., and Gunselman S.J. Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc Natl Acad Sci USA 94 (1997) 259-264
5. Olinski R., Zastawny T., Budzbon J., et al. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett 309 (1992) 193-198
6. Shibutani S., Takeshita M., and Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349 (1991) 431-434
7. Cheng K.C., Cahill D.S., Kasai H., et al. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267 (1992) 166-172
8. Le Page F., Margot A., Grollman A.P., et al. Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. Carcinogenesis 16 (1995) 2779-2784
9. Malins D.C., and Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 51 (1991) 5430-5432
10. Malins D.C., Holmes E.H., Polissar N.L., et al. The etiology of breast cancer: characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71 (1993) 3036-3043
11. Asami S., Hirano T., Yamaguchi R., et al. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 56 (1996) 2546-2549
12. Asami S., Manabe H., Miyake J., et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18 (1997) 1763-1766
13. Yamazaki H., Inoue T., Koizumi M., et al. Urinary 8-hydroxy-2′-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy. Oncol Rep 13 (2005) 847-851
14. Giovannini C., Chieco P., Bertaccini A., et al. Checkpoint effectors CDKN1A and Gadd45 correlate with oxidative DNA damage in human prostate carcinoma. Anticancer Res 24 (2004) 3955-3960
15. Chiou C.C., Chang P.Y., Chan E.C., et al. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 334 (2003) 87-94
16. Miyake H., Hara I., Gleave M.E., et al. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61 (2004) 318-323
17. Chen L., Stacewicz-Sapuntzakis M., Duncan C., et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 93 (2001) 1872-1879
18. Huang D., Casale Jr. G., Tian N., et al. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. Cancer Epidemiol Biomarkers Prev 16 (2007) 1371-1381
19. Bonner R.B., Hurst R.E., Rao J., et al. Instrumentation, accuracy and quality control in development of quantitative fluorescence image analysis. Tumor Marker Protocols vol. 14 (1998), Hanausek Press, Totowa, NJ 181
20. Hemstreet G.P., Hurst R.E., and Bonner R.B. Selection and development of biomarkers for bladder cancer. In: Hanausek M., and Walaszek Z. (Eds). Tumor Marker Protocols vol. 14 (1998), Humana Press, Totowa, NJ 37
21. Park E.M., Shigenaga M.K., Degan P., et al. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc Natl Acad Sci USA 89 (1992) 3375-3379
22. 1-treated rat liver and human oral mucosal cells. Cancer Res 56 (1996) 683-688
23. Neville N.C., Tam A., Nyska R.R., et al. Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants. Prostate 66 (2006) 57-69
24. Fidler I.J. The biology of human cancer metastasis. Acta Oncol 30 (1991) 668-675
25. Wehbi N.K., Dugger A.L., Bonner R.B., et al. Pan-cadherin as a high level phenotypic biomarker for prostate cancer. J Urol 167 (2002) 2215-2221
26. Miyake H., Hara I., Kamidono S., et al. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol 171 (2004) 1533-1536